Provectus Biopharmaceuticals Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.02 |
Market Cap |
$26.92 M |
Shares Outstanding |
384.62 M |
Public Float |
368.35 M |
Address |
10025 Investment Drive Knoxville Tennessee 37932 United States |
Employees | - |
Website | http://www.provectusbio.com |
Updated | 07/08/2019 |
Provectus Biopharmaceuticals, Inc. is a development stage biopharmaceutical company, which engages in the development of ethical pharmaceuticals for oncology and dermatology indications. Its prescription drugs treats several life threatening cancers including metastatic melanoma, liver cancer, and breast cancer. The company was founded by Eric A. |